Actively Recruiting
Pathogenic Study of Adult Immune Enteropathies
Led by Institut National de la Santé Et de la Recherche Médicale, France · Updated on 2025-09-18
200
Participants Needed
4
Research Sites
678 weeks
Total Duration
On this page
Sponsors
I
Institut National de la Santé Et de la Recherche Médicale, France
Lead Sponsor
I
Imagine Institute
Collaborating Sponsor
AI-Summary
What this Trial Is About
The study focuses the mechanisms underlying the loss of intestinal homeostasis in celiac disease, refractory celiac disease and other immune diseases such as monogenic enteropathy, inflammatory bowel diseases or drug induced intestinal diseases. Mechanisms of transformation of lymphocytes leading to onset of lymphomatous complications of immune enteropathies will be investigated. Mechanisms of loss of hepatic lymphocytic homeostasis will also be assessed in liver associated diseases.
CONDITIONS
Official Title
Pathogenic Study of Adult Immune Enteropathies
Who Can Participate
Eligibility Criteria
You may qualify if you...
- 18 years or over
- Affiliated to social insurance
- Signed informed consent
You will not qualify if you...
- Pregnancy
- Under guardianship
- Not able to sign informed consent
AI-Screening
AI-Powered Screening
Complete this quick 3-step screening to check your eligibility
Trial Site Locations
Total: 4 locations
1
Hôpital Henri Mondor
Créteil, France, 94010
Not Yet Recruiting
2
Hôpital Bicêtre
Le Kremlin-Bicêtre, France, 94270
Not Yet Recruiting
3
Hôpital Saint Louis
Paris, France, 75010
Not Yet Recruiting
4
Hôpital Cochin
Paris, France, 75014
Actively Recruiting
Research Team
G
Georgia MALAMUT, MD, PhD
CONTACT
A
Anaïs LEVESCOT, MD, PhD
CONTACT
How is the study designed?
Study Type
OBSERVATIONAL
Masking
N/A
Allocation
N/A
Model
N/A
Primary Purpose
N/A
Number of Arms
7
Not the Right Trial for You?
Explore thousands of other clinical trials that might be a better match.
Sign up to get personalized trial recommendations delivered to your inbox.
Already have an account? Log in here